Heart Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years of age or older (male or female)
- You have been diagnosed with heart failure (any type)
- Your heart failure diagnosis was made more than 3 months ago
- You do not currently have significant signs of fluid build-up in your body, such as crackling sounds in the lungs or significant leg swelling beyond mild ankle swelling
- You are affiliated with the French social security system
- You have received full information about the study and are willing to sign a consent form
Who may not be able to join:
- You have had a natriuretic peptide blood test (a specific heart-related test) done in the last 30 days that is already available at the time of your enrolment visit
- You have a lung or chest lining condition (such as severe emphysema, long-term fluid around the lungs, or lung scarring) that would make lung ultrasound scans unreliable
- You have been diagnosed with, or are suspected of having, a condition called cardiac amyloidosis (a disease where abnormal proteins build up in the heart)
- You have a serious problem with one of your heart valves that is not caused by another condition
- You are pregnant, in labour, or currently breastfeeding
- You are under a legal protection order such as guardianship or a similar arrangement (confirm with trial site)
- You are currently restricted of your freedom by a court or administrative decision
- You are currently receiving involuntary psychiatric care under specific French public health laws (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 3 83 15 74 96
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Death within 30 days (composite endpoint); Hospitalization for heart failure within 30 days (composite endpoint); Changes in N-terminal pro b-type natriuretic peptide (NtProBNP) between randomization and D30 (composite endpoint)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.